Lin J, Meng H, Shafeng N, Li J, Sun H, Yang X
Front Neurol. 2024; 15:1482936.
PMID: 39659962
PMC: 11628379.
DOI: 10.3389/fneur.2024.1482936.
Garcia-Garcia E, Carreras-Caballe M, Coll-Manzano A, Ramon-Lainez A, Besa-Selva G, Perez-Navarro E
Front Neurosci. 2024; 18:1394478.
PMID: 38903599
PMC: 11188336.
DOI: 10.3389/fnins.2024.1394478.
Alkahtani S, Alkahtane A, Alarifi S
Physiol Res. 2024; 73(2):189-203.
PMID: 38710051
PMC: 11081191.
Walker R, Peikert K, Jung H, Hermann A, Danek A
Contact (Thousand Oaks). 2023; 6:25152564231210339.
PMID: 38090146
PMC: 10714877.
DOI: 10.1177/25152564231210339.
Henkel L, Kankowski S, Moellenkamp T, Smandzich N, Schwarz S, Di Fonzo A
Cells. 2023; 12(2).
PMID: 36672158
PMC: 9856678.
DOI: 10.3390/cells12020223.
Yeast as a Model to Find New Drugs and Drug Targets for -Dependent Neurodegenerative Diseases.
Kaminska J, Soczewka P, Rzepnikowska W, Zoladek T
Int J Mol Sci. 2022; 23(9).
PMID: 35563497
PMC: 9104724.
DOI: 10.3390/ijms23095106.
Do foetal transplant studies continue to be justified in Huntington's disease?.
Bartley O, Lelos M, Gray W, Rosser A
Neuronal Signal. 2021; 5(4):NS20210019.
PMID: 34956650
PMC: 8674623.
DOI: 10.1042/NS20210019.
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer's Disease.
Schulz J
Stem Cells Int. 2021; 2021:5511630.
PMID: 34122554
PMC: 8172295.
DOI: 10.1155/2021/5511630.
Reduced Expression of GABA Receptor Alpha2 Subunit Is Associated With Disinhibition of DYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons.
Staege S, Kutschenko A, Baumann H, Glass H, Henkel L, Gschwendtberger T
Front Cell Dev Biol. 2021; 9:650586.
PMID: 34095114
PMC: 8176025.
DOI: 10.3389/fcell.2021.650586.
Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Peikert K, Glass H, Federti E, Matte A, Pelzl L, Akgun K
J Pers Med. 2021; 11(5).
PMID: 34068769
PMC: 8150322.
DOI: 10.3390/jpm11050392.
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.
Peikert K, Federti E, Matte A, Constantin G, Pietronigro E, Fabene P
Acta Neuropathol Commun. 2021; 9(1):81.
PMID: 33941276
PMC: 8091687.
DOI: 10.1186/s40478-021-01181-y.
Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
Kutschenko A, Staege S, Grutz K, Glass H, Kalmbach N, Gschwendtberger T
Int J Mol Sci. 2021; 22(7).
PMID: 33808167
PMC: 8037318.
DOI: 10.3390/ijms22073565.
The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.
Le Cann K, Foerster A, Rosseler C, Erickson A, Hautvast P, Giesselmann S
Sci Rep. 2021; 11(1):6934.
PMID: 33767215
PMC: 7994641.
DOI: 10.1038/s41598-021-85656-x.
Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency.
Wardaszka P, Soczewka P, Sienko M, Zoladek T, Kaminska J
Int J Mol Sci. 2021; 22(3).
PMID: 33530471
PMC: 7865597.
DOI: 10.3390/ijms22031193.
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis.
Starost L, Lindner M, Herold M, Xu Y, Drexler H, Hess K
Acta Neuropathol. 2020; 140(5):715-736.
PMID: 32894330
PMC: 7547031.
DOI: 10.1007/s00401-020-02217-8.
The application of in vitro-derived human neurons in neurodegenerative disease modeling.
DSouza G, Rose S, Knupp A, Nicholson D, Keene C, Young J
J Neurosci Res. 2020; 99(1):124-140.
PMID: 32170790
PMC: 7487003.
DOI: 10.1002/jnr.24615.
Combined Dendritic and Axonal Deterioration Are Responsible for Motoneuronopathy in Patient-Derived Neuronal Cell Models of Chorea-Acanthocytosis.
Glass H, Neumann P, Pal A, Reinhardt P, Storch A, Sterneckert J
Int J Mol Sci. 2020; 21(5).
PMID: 32151030
PMC: 7084777.
DOI: 10.3390/ijms21051797.
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression.
Para C, Bose P, Pshezhetsky A
J Clin Med. 2020; 9(3).
PMID: 32106459
PMC: 7141115.
DOI: 10.3390/jcm9030616.
Increased Neuronal Differentiation Efficiency in High Cell Density-Derived Induced Pluripotent Stem Cells.
Srimasorn S, Kirsch M, Hallmeyer-Ellgner S, Lindemann D, Storch A, Hermann A
Stem Cells Int. 2019; 2019:2018784.
PMID: 31871463
PMC: 6913159.
DOI: 10.1155/2019/2018784.
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination.
Langer L, Ward J, Archer T
Elife. 2019; 8.
PMID: 31033435
PMC: 6538374.
DOI: 10.7554/eLife.45672.